Atomfair Brainwave Hub: SciBase II / Artificial Intelligence and Machine Learning / AI-driven drug discovery and synthesis

AI-driven drug discovery and synthesis

Showing 157-168 of 245 articles

With 3-year commercialization paths for synaptic vesicle recycling therapeutics

Optimizing gut-brain axis modulation using precision probiotic strains and neural biomarkers

Microbiome rejuvenation through CRISPR-based phage therapy targeting antibiotic-resistant pathogens

For immediate pandemic response using CRISPR-based viral detection systems

Combining ancient and modern methods to revive lost medicinal compounds

Designing solvent selection engines for sustainable pharmaceutical manufacturing

Developing continuous flow chemistry systems for scalable senolytic drug discovery

Enhancing drug discovery via multimodal fusion architectures for molecular property prediction

Targeting 2025 regulatory approval for CRISPR-based neurodegenerative therapies

Enhancing tumor detection by integrating neutrino physics with medical imaging

Optimizing protein folding intermediates through solvent selection engines for enhanced stability

With flow chemistry robots to accelerate drug discovery pipelines